1. Market Research
  2. > Advanced IT
  3. > Internet Of Things Market Trends
The Healthcare Internet of Things: A Network of Opportunities for All (2016)

The Healthcare Internet of Things: A Network of Opportunities for All (2016)

  • October 2016
  • ID: 4275626
  • Format: PDF
  • By Firstword Pharma


Table of Contents


Partnering people and technology to build more productive relationships

Clinical and commercial success in pharma has always been dependent on relationships. Now our sector and others are seeing people and technology come together in incredibly exciting new ways, creating stronger connections and enabling continuous and productive conversations to take place in real time.

The opportunities for pharma are immense – but finding the right path to follow is challenging.
The Healthcare Internet of Things: A Network of Opportunities for All casts a candid eye over the latest developments and plots a course for pharmaceutical companies wanting to maximise long-term commercial advantage. Based on in-depth discussions with 10 senior industry leaders at the forefront of technology, this report examines how the Internet of Things (IoT) phenomenon can be usefully applied to foster more communicative relationships between pharma, patients, physicians and payers.

Key Features
- Clear definition of IoT and an explanation of what it encompasses – including the technologies, tools and approaches that exist today and are already delivering value.
- Outline of how the organisational structures within pharma need to evolve to adopt an IoT strategy, including specialist partnerships, leadership culture and data science capabilities.
- Expert views on how IoT can be harnessed to power-charge relationships with physicians, patient segments, and payers.
- Detailed discussion on what an IoT enabled future could look like plus a clear view on what needs to be in place to get there.
- Exploration of how IoT can speed the time-to-market of drugs and drive cost-effective processes.

Key Benefits
- Enables more joined-up thinking: Supports a holistic approach - IoT can be applied across multiple areas from trial management to market access, patient-centricity to payer liaison.
- Facilitates informed decision-making: Gain the insight needed to formulate targeted IoT strategies that fit with wider business plans, goals and technology capabilities.
- Manages business expectations: Draw on case studies with pharma and other industries to identify evidence of benefits being realised and clarity on what is possible.
- Provides a clear plan of action: Find out what needs to be in place and the potential pitfalls. Understand the route to setting up and rolling out an IoT strategy.

Why IoT matters for pharma
A highly connected healthcare ecosystem will ultimately help pharma serve patients better. IoT may be in its infancy today, however those that implement gradual, planned and controlled changes now will be best placed to realise the benefits of a connected future.

Earlier diagnosis is widely expected to be one of the most important IoT outcomes. The huge leaps made by IBM’s Watson is a prime example of what is already possible. Ultimately, IoT is a business issue, not just an IT one, as it has the potential to fundamentally change the way clinical and commercial decisions are made across the drug lifecycle.

Key Questions Answered By This Report:
- Evolution or revolution? What structures and business models are needed to leverage IoT to meet commercial and/or clinical business objectives?
- What evidence already exists to support the strategic, financial and operational benefits gained from putting in place an IoT strategy?
- What can pharma learn from other industries with more evolved experience in applying IoT thinking to their stakeholder relationships?
- Who should pharma look to partner with and what type of partner companies should be considered? Are single or multiple relationships required?

Expert Views
- Duncan Arbour, Innovation Lead at Inventive Health Europe
- Matt Bolton, Associate Strategy Director at Clear M&C Saatchi
- Christopher Colucci, Head of Enterprise Applications at Insmed
- Philipp Diesinger, Global Chief Data Scientist at Boehringer
- Laurent Flouret, Director – Global Digital Strategy & Innovation at Sanofi
- Daniel George, Digital Experience Leader in Global Commercial Excellence at AstraZeneca
- Magnus Jörntén-Karlsson, Project Director, Pharmaceutical Innovations, AstraZeneca R&D
- Valerio Nannini, Senior Vice President, Head of Strategies and Performance at Nestlé
- Daniel Ramirez, International Head of Business Development, LEO Innovation Lab, LEO Pharma A/S
- Jane Rhodes, Senior Director of New Initiatives for the Value-Based Medicine team at Biogen

“Now, you can have more digital eyes and ears on the pre-clinical, clinical and real world data, and far greater ability to make sense of this. It’s the potential for no meaningful change in data, no matter how tiny, to be missed.”
Duncan Arbour, Inventive Health Europe

“The nature of the IoT in healthcare is that it brings the patient to the fore in their treatment journey, and as such, if pharma can develop its position here, it can develop closer relationships with patients.”
Matt Bolton of Clear M&C Saatchi

“IoT has the potential to disrupt traditional methods of clinical development processes, improve decision making and speed up drug development.” Jane Rhodes of Biogen

Who will benefit from this report?
- Senior-leadership teams and key decision-makers
- Commercial and clinical department leads
- Relationship management and customer care specialists
- Technology departments and IT investment decision-makers
- Human resources and talent finders
- Payer liaison
- Trial designers and managers

Content Highlights
- Growing connectivity as momentum for the Internet-of-Things (IoT)
- Embracing the IoT in healthcare and pharma
- Key insights
- Key drivers of the IoT
- Patient-centricity and the IoT
- The potential of the IoT for other stakeholders
- Physicians and HCPs
- Pharmacies
- Payers
- The current status of the healthcare IoT
- The Tools of the IoT
- Key insights
- Wearables
- Analytics
- Cloud computing
- Cognitive systems
- Blockchain
- The IoT as a strategic consideration for pharma and healthcare
- Key insights
- Patient monitoring and improved diagnosis, adherence and outcomes
- R&D and real-world data
- Value-adding services
- Customer satisfaction and customer experience management
- Faster time-to-market and commercial effectiveness
- Challenges and Resistors to uptake of the IoT
- Key insights
- Are the regulations around IoT solution development clearly defined?
- Will IoT be data secured?
- Is technology mature enough?
- What does a successful IoT pilot programme look like?
- Will there be an ROI from the IoT?
- Accentuating positive opportunities from the IoT
- Key insights
- Learning from other industries
- Collaborating with the best for effective business models
- Optimising touchpoints for customer engagement
- Allow the IoT to shake up clinical trials and R&D
- Building a truly integrated, trusted network of care
- Organisational structure and the IoT
- Key insights
- Think data, think connectivity
- Data science capabilities
- Tech-savvy leadership to facilitate IoT success
- The Future of IoT in healthcare
- Key insights
- Unparalleled healthcare access and communication
- Regulatory agencies need to be supportive
- Change in business model
- Conclusions
- Expert biographies

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
IDC FutureScape: Worldwide Mining 2020 Predictions

IDC FutureScape: Worldwide Mining 2020 Predictions

  • $ 4500
  • October 2019

This IDC study contains the outlook of IDC Energy Insights' analyst team for the worldwide mining industry for 2020-2025. The outlook is presented through the lens of the 10 predictions that make up, in ...

Japan Internet of Things Forecast by Technology, 2019-2023

Japan Internet of Things Forecast by Technology, 2019-2023

  • $ 4500
  • October 2019

This IDC study is a translation of the Japanese document (IDC #JPJ44558619) and analyzes the current Internet of Things (IoT) spending and forecasts spending growth in the IoT market from 2019 to 2023 ...

End User Priorities in Digital Transformation, Europe, 2019

End User Priorities in Digital Transformation, Europe, 2019

  • $ 3000
  • September 2019

Across industries, companies expect to increase their IT and Communications investments by 22%. Almost 100% of businesses in Europe have a digital transformation today; however, 19% believe they are behind ...

IoT Platforms and Software $ 2052 October 2019

Global IoT Sensors Industry $ 4950 October 2019


Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on